Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
3051
PUT
DELISTED
Vital Energy
VTLE
| $7.24M | ﹤0.01% |
105,000
-12,000
| -10% | -$963K |
|
3052
Vertiv
VRT
$113B
| $7.24M | ﹤0.01% |
880,617
-2,560,444
| -74% | -$29M |
|
3053
iShares US Healthcare ETF
IYH
$3.75B
| $7.24M | ﹤0.01% |
134,520
+130,775
| +3,492% | +$7.18M |
|
3054
Bumble
BMBL
$358M
| $7.23M | ﹤0.01% |
256,939
-2,352,810
| -90% | -$63.9M |
|
3055
PUT
Signet Jewelers
SIG
$3.52B
| $7.23M | ﹤0.01% |
135,300
+53,800
| +66% | +$3.51M |
|
3056
PUT
Corteva
CTVA
$51.2B
| $7.23M | ﹤0.01% |
133,500
-14,000
| -9% | -$813K |
|
3057
CALL
Chemours
CC
$2.39B
| $7.23M | ﹤0.01% |
225,700
-22,100
| -9% | -$813K |
|
3058
CALL
Fluor
FLR
$7B
| $7.22M | ﹤0.01% |
296,700
-92,800
| -24% | -$2.49M |
|
3059
CALL
CNX Resources
CNX
$5.28B
| $7.22M | ﹤0.01% |
438,500
+137,400
| +46% | +$2.81M |
|
|
CIVI
3060
CALL
DELISTED
Civitas Resources
CIVI
| $7.22M | ﹤0.01% |
138,000
+76,364
| +124% | +$4.98M |
|
3061
CALL
iShares Russell 2000 Value ETF
IWN
$14.7B
| $7.22M | ﹤0.01% |
53,000
+28,700
| +118% | +$4.27M |
|
3062
PUT
C3.ai
AI
$1.54B
| $7.21M | ﹤0.01% |
394,700
+85,300
| +28% | +$1.57M |
|
3063
CALL
iShares US Medical Devices ETF
IHI
$3.46B
| $7.2M | ﹤0.01% |
142,700
+24,900
| +21% | +$1.36M |
|
3064
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$799M
| $7.19M | ﹤0.01% |
229,372
-218,793
| -49% | -$7.34M |
|
|
RAPT
3065
CALL
DELISTED
RAPT Therapeutics
RAPT
| $7.19M | ﹤0.01% |
49,263
+47,750
| +3,156% | +$6.36M |
|
|
ESM
3066
DELISTED
ESM Acquisition Corporation
ESM
| $7.19M | ﹤0.01% |
733,828
-7
| -0% | -$69 |
|
3067
Corsair Gaming
CRSR
$1.41B
| $7.19M | ﹤0.01% |
547,574
+189,227
| +53% | +$3.09M |
|
3068
Global X US Infrastructure Development ETF
PAVE
$14.4B
| $7.19M | ﹤0.01% |
315,719
+282,084
| +839% | +$7.22M |
|
|
SCPL
3069
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $7.18M | ﹤0.01% |
513,682
-93,343
| -15% | -$1.25M |
|
|
PPL
3070
PUT
PPL Corp
PPL
$27.1B
| $7.15M | ﹤0.01% |
263,700
+73,400
| +39% | +$2.11M |
|
3071
PUT
MPLX
MPLX
$60.3B
| $7.15M | ﹤0.01% |
245,300
-14,900
| -6% | -$477K |
|
3072
Chord Energy
CHRD
$7.51B
| $7.15M | ﹤0.01% |
58,769
+56,326
| +2,306% | +$8.25M |
|
3073
PUT
Credit Acceptance
CACC
$6.1B
| $7.15M | ﹤0.01% |
15,100
-3,900
| -21% | -$2.15M |
|
3074
Invesco S&P International Developed Quality ETF
IDHQ
$986M
| $7.15M | ﹤0.01% |
+299,714
| New | +$7.79M |
|
3075
Caterpillar
CAT
$394B
| $7.15M | ﹤0.01% |
39,975
-63,127
| -61% | -$13.3M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.